Our Products

Pre-filled syringe / Vial

Active immunization for broad protection

Administer intramuscularly or subcutaneously as directed by a healthcare professional.

24 months under refrigerated conditions (2°C - 8°C)

Single-dose vial

Stimulates the immune system to produce antibodies against diphtheria, tetanus, and pertussis toxins.

Administer intramuscularly as directed by immunization schedules.

36 months sob conditions refrigerated (2°C - 8°C)

Lyophilized powder with diluent

Provides robust immunity against Hib infections.

Reconstitute with provided diluent before intramuscular injection.

36 months under refrigerated conditions (2°C - 8°C)

Multi-dose vial with diluent

Induces a neutralizing antibody response to measles and rubella viruses.

Reconstitute and administer subcutaneously.

24 months under refrigerated conditions (2°C - 8°C)

Pre-filled syringe / Single-dose vial

Promotes cellular and humoral immunity against the SARS-CoV-2 virus.

Administer intramuscularly.

24 months under refrigerated conditions (2°C - 8°C)

Multi-dose vial

Utilizes a viral vector to deliver the spike protein gene, inducing strong immune protection.

Intramuscular injection, usually requiring a two-dose primary series.

6 months under refrigerated conditions (2°C - 8°C)

Pre-filled syringe / Dual-chamber formulation

Provides simultaneous protection against six major childhood diseases.

Administer intramuscularly following standard pediatric vaccination schedules.

36 months under refrigerated conditions (2°C - 8°C)

0.5 ml per pre-filled syringe

Provides broad protection against 13 pneumococcal serotypes using dual TT/DT carrier system — the world's first of its kind.

Administer intramuscularly. Store and ship at 2–8°C. Do not freeze.

24 months under refrigerated conditions (2°C - 8°C)

Lyophilized powder with diluent

World-leading production process using ultrasound-crushing of virus harvested in outside cell factory — avoids contamination and improves efficiency.

Reconstitute and administer subcutaneously.

18 months under refrigerated conditions (2°C - 8°C)

10 µg (children) / 20 µg (adults) / 60 µg (high-dose) per dose; 1.0 ml or 0.5 ml per vial

Stimulates production of specific antibodies against hepatitis B surface antigen (HBsAg). The world's first 60 µg hepatitis B vaccine.

Administer intramuscularly. Three-dose series at 0, 1, and 6 months.

24 months under refrigerated conditions (2°C - 8°C)

0.5 ml per vial

Key project of the Science and Technology Ministry of China. Provides broad coverage against 23 pneumococcal serotypes.

Administer intramuscularly or subcutaneously as a single dose.

24 months under refrigerated conditions (2°C - 8°C)

Sterile powder for injection; supplied with 1.0 ml sterile water in a pre-filled syringe. After reconstitution, each vial is 1.0 ml; rabies vaccine titer not less than 2.5 IU per vial.

Second full vaccine production technology introduction project in China. Supported by the Science and Technology Commission of Beijing Municipal Government.

Reconstitute with provided sterile water. Administer intramuscularly. Follow pre- or post-exposure immunization program.

Store at 2–8°C away from light

0.5 ml per bottle after reconstitution. Measles and rubella virus dose not less than 3.0 lgCCID50; mumps virus not less than 3.7 lgCCID50.

Induces neutralizing antibody responses to measles, mumps and rubella viruses simultaneously.

Reconstitute and administer subcutaneously. Store and transport at 2–8°C away from light.

18 months

DTaP-IPV: 0.5 ml per dose; Hib: lyophilized powder — after reconstitution each bottle contains 0.5 ml with Hib polysaccharide 10 µg. Active constituents: DT, TT, PT, FHA, PRN, Hib, Polio type 1 2 3.

Simultaneous protection against five major childhood diseases in a single injection.

Reconstitute Hib component with DTaP-IPV suspension, then administer intramuscularly. Store and transport at 2–8°C away from light.

36 months

0.5 ml per dose; each 0.5 ml hemagglutinin containing influenza virus strains should be 15 µg. Active constituent: hemagglutinin of various influenza virus strains.

Provides broad seasonal influenza protection against four circulating strains (two influenza A and two influenza B lineages).

Administer intramuscularly. Store and transport at 2–8°C away from light.

12 months

0.5 ml per dose. Active constituents: Type P1 15 DU/dose, Type P2 45 DU/dose, Type P3 45 DU/dose.

Provides protection against all three poliovirus serotypes using Sabin strain grown on Vero cells.

Administer intramuscularly or subcutaneously following standard pediatric immunization schedules.

Store and transport at 2–8°C away from light